top of page
All Articles


Do the Right Thing With Purdue Pharma Funds
Robert Kent argues that Purdue Pharma settlement money should be treated differently from other opioid funds. He calls for affected families to review spending decisions and urges governments to direct the money toward families carrying the trauma, loss, and generational consequences of the opioid epidemic.
Robert Kent
Aug 213 min read


American Substance Use Disorder Treatment Is a Predatory Cash Grab
Joshua Bennett-Johnson, LADC-II, a licensed counselor with 14 years' experience, argues that the for-profit rehab model focuses more on billing, marketing, insurance, luxury amenities, and short-term stabilization than long-term recovery. The article urges readers to scrutinize patient brokering, revolving-door treatment, underuse of medication-assisted treatment, and weak aftercare.
Joshua Bennett-Johnson
Jun 137 min read


Why I Support Harm Reduction
Rob Kent, Esq. writes from nearly 20 years of work in state and federal drug policy, including his time as general counsel at the New York State Office of Addiction Services and Supports. In this Harm Reduction Series article, he explains how witnessing preventable loss changed his view of harm reduction and strengthened his belief in the full continuum of care. His central question is direct: how can we help people stay alive and get better?
Robert Kent
Jun 64 min read
bottom of page

